跳至主要内容
临床试验/CTRI/2014/12/005244
CTRI/2014/12/005244招募中4 期

A double blind randomized control trial to compare the effectiveness, safety and tolerability of bacillus-calmette-guerin (BCG) vaccine and purified protein derivative (PPD) of tuberculin antigen in the treatment of multiple viral warts.

Medical College Kolkata0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • i.Male or female patients between 18 and 65 years of age (both inclusive)
  • ii.Multiple viral warts (number > 10)
  • iii.Patients who give their informed consent

排除标准

  • i.Pregnant or lactating women
  • ii.Any evidence of immunosuppression (egg HIV infection, Organ transplantation, long term steroid use etc.)
  • iii.Any other systemic disease (egg liver, kidney disorder)
  • iv.Patients not giving their informed consent
  • v.Presence of mucosal wart(s)

研究者

相似试验